ArticleLung cancer (Amsterdam, Netherlands)2018

Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials.

Hossein Maymani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.